Abstract P3-09-03: A phase II study of pembrolizumab and eribulin in patients with HR-positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes (KELLY study)
J. Peréz-García, A. Llombart-Cussac, E. Holgado, G. Curigliano, E. Miranda, J. L. Alonso-Romero, B. Bermejo, L. Calvo, V. Carañana, Susana de la Cruz Sánchez, M. Cortés, R. M. Vázquez, A. Prat, M. R. Borrego, M. Sampayo, M. Seguí, J. Soberino, A. Malfettone, P. Schmid, J. Cortés
{"title":"Abstract P3-09-03: A phase II study of pembrolizumab and eribulin in patients with HR-positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes (KELLY study)","authors":"J. Peréz-García, A. Llombart-Cussac, E. Holgado, G. Curigliano, E. Miranda, J. L. Alonso-Romero, B. Bermejo, L. Calvo, V. Carañana, Susana de la Cruz Sánchez, M. Cortés, R. M. Vázquez, A. Prat, M. R. Borrego, M. Sampayo, M. Seguí, J. Soberino, A. Malfettone, P. Schmid, J. Cortés","doi":"10.1158/1538-7445.sabcs19-p3-09-03","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20307,"journal":{"name":"Poster Session Abstracts","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster Session Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.sabcs19-p3-09-03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
